Richard Glaze

CIK: 0002025615

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CNMD

CONMED Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

CNMD
CONMED Corp
Nov 21, 2025
Sale(S)
Direct
257 shares at avg. $41.21$11K
CNMD
CONMED Corp
Nov 20, 2025
Exercise(M)
Direct
375 shares-
CNMD
CONMED Corp
Nov 20, 2025
Tax Payment(F)
Direct
118 shares at avg. $40.63$5K
CNMD
CONMED Corp
Mar 3, 2025
Award(A)
Options To Purchase Common Stock
Direct
11.8K shares-
CNMD
CONMED Corp
Feb 11, 2025
Sale(S)
Direct
257 shares at avg. $65.35$17K
CNMD
CONMED Corp
Nov 20, 2024
Tax Payment(F)
Direct
118 shares at avg. $70.69$8K
CNMD
CONMED Corp
Nov 20, 2024
Exercise(M)
Direct
375 shares-

		Type	Shares	Price		Ownership
Nov 21, 2025	CNMD CONMED Corp	Sale(S)	257	$41.21	$10,591	Direct
Nov 20, 2025	CNMD CONMED Corp	Exercise(M)	375	-	-	Direct
Nov 20, 2025	CNMD CONMED Corp	Tax Payment(F)	118	$40.63	$4,794	Direct
Mar 3, 2025	CNMD CONMED Corp	Award(A) Options To Purchase Common Stock	11,750	-	-	Direct
Feb 11, 2025	CNMD CONMED Corp	Sale(S)	257	$65.35	$16,796	Direct
Nov 20, 2024	CNMD CONMED Corp	Tax Payment(F)	118	$70.69	$8,341	Direct
Nov 20, 2024	CNMD CONMED Corp	Exercise(M)	375	-	$0	Direct

1-7 of 7 transactions

About Glaze Richard

Glaze Richard (SEC CIK 0002025615) files insider reports with the SEC as Chief Information Officer of CONMED Corp (CNMD).

Signal8 holds 5 ownership filings by Glaze Richard, all Form 4s, filed between Nov 21, 2024 and Nov 24, 2025. Those filings report 7 transactions, from Nov 20, 2024 to Nov 21, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Glaze Richard's filings is in LARGO, FL.

Recent filings by Glaze Richard

Nov 21, 2025: Open-market sale of CNMD shares (Form 4, code S).
Nov 20, 2025: Option exercise of CNMD shares (Form 4, code M).
Nov 20, 2025: Tax withholding of CNMD shares (Form 4, code F).
Mar 3, 2025: Grant or award of CNMD derivative securities (Form 4, code A).
Feb 11, 2025: Open-market sale of CNMD shares (Form 4, code S).

Other insiders filing for CONMED Corp (CNMD)

Kelderman Kim, Director
Gallagher John E, Executive Vice President & CFO
Martin Celine Christine, Director
Mirviss Jeffrey B., Director
Bronson David M., Director
Council LaVerne H, Director

How to read Form 4 transaction codes